Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies
-
Published:2024
Issue:4
Volume:3
Page:539-550
-
ISSN:2772-5723
-
Container-title:Gastro Hep Advances
-
language:en
-
Short-container-title:Gastro Hep Advances
Author:
Peyrin-Biroulet LaurentORCID,
Colombel Jean-Frederic,
Louis Edouard,
Ferrante Marc,
Motoya Satoshi,
Panaccione Remo,
Torres Joana,
Ungaro Ryan C.,
Kligys Kristina,
Kalabic Jasmina,
Zambrano Javier,
Zhang Yafei,
D'Haens Geert